Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taipei Exchange (TPEx: 6446) and are expanding our global presence with operations in the U.S., Japan, China and Korea, along with a world-class biologics production facility in Taichung. Integrate and analyze multi-omics datasets, including bulk and single-cell transcriptomics, spatial omics, proteomics, human genetics, functional genomics, and clinical or translational data, to identify disease-relevant cell states, pathways, biomarkers, and therapeutic targets.